Types of Pancreatic Cancer, How They’re Diagnosed & Treated

Your pancreas is the unsung backstage crew of digestion and blood sugar control. It doesn’t ask for applause,
it just quietly makes enzymes and hormones and keeps the show running. So when pancreatic cancer shows up,
it’s like the stage manager suddenly starts rearranging the set during the performanceeveryone feels it,
but it can be maddeningly hard to spot early.

This guide breaks down the main types of pancreatic cancer, what doctors look for during
pancreatic cancer diagnosis, and how treatment decisions are madefrom surgery to chemotherapy
to newer targeted options. It’s in-depth, practical, and yes, sprinkled with a little humor (because sometimes
that’s the only thing that makes medical reading tolerable).

Pancreas 101: Why This Cancer Can Be Tricky

The pancreas sits deep in the abdomen, tucked behind the stomach. That’s great for protecting it from
everyday bumps… and not so great when you’re trying to detect a small tumor on a routine exam.
Many early pancreatic tumors don’t cause obvious symptoms, and when symptoms finally appear, they often mimic
more common problems like gallbladder issues, ulcers, or pancreatitis.

Another complication: “pancreatic cancer” isn’t one single disease. Different tumors start from different
pancreatic cells, grow at different speeds, and respond differently to treatment. Knowing the exact type is
a big deallike knowing whether you’re fighting a house fire, a grease fire, or an electrical fire.
Same building, different strategy.

Types of Pancreatic Cancer

Most pancreatic tumors fall into two big families based on the kind of cells they begin in:
exocrine (digestive enzyme-related) and neuroendocrine (hormone-related).
Each family includes subtypes with different behaviors and treatment approaches.

1) Exocrine Pancreatic Cancers (the most common)

The majority of the pancreas is made of exocrine cells and ducts that help digest food. Cancers that start
here are the “classic” pancreatic cancers most people mean when they say the term.

Pancreatic ductal adenocarcinoma (PDAC)

This is the headline-maker. PDAC usually starts in the ducts that carry digestive enzymes out of the pancreas.
It accounts for the vast majority of exocrine pancreatic cancers. It’s also the subtype most associated with
late diagnosis, because early symptoms can be subtle.

Variants of adenocarcinoma (rarer, but important)

Some tumors look different under the microscope and may behave differently, such as:

• Adenosquamous carcinoma (has gland-like and squamous features)
• Colloid (mucinous non-cystic) carcinoma (often associated with mucin production)
• Undifferentiated carcinoma (more aggressive appearance)

Acinar cell carcinoma

Acinar cells make digestive enzymes. Cancers starting here are uncommon compared with PDAC. They can present
differently and sometimes have distinct molecular features that influence therapy choices.

Cystic neoplasms that can turn cancerous

Not all pancreatic cysts are cancer, but some cystic lesions can become malignant or already contain cancer.
Doctors often evaluate cysts carefully with imaging and sometimes endoscopic sampling. Examples include:

• IPMN (intraductal papillary mucinous neoplasm): can progress and may be connected to the ducts
• Mucinous cystic neoplasm (MCN): typically occurs in certain parts of the pancreas and has malignant potential

Practical takeaway: If your report mentions a cystic lesion, don’t assume the worstand don’t ignore it
either. The goal is careful evaluation, not panic-buying a year’s supply of kale.

2) Pancreatic Neuroendocrine Tumors (pNETs)

Neuroendocrine tumors arise from hormone-producing islet cells. They’re less common than PDAC and often grow
more slowly. Some pNETs make hormones that cause noticeable symptoms, which can sometimes lead to earlier detection.

Functional vs. nonfunctional pNETs

• Functional pNETs release excess hormones and may cause specific syndromes.
  Example: an insulinoma can cause low blood sugar episodes (shakiness, sweating, confusion).
• Nonfunctional pNETs don’t cause hormone-related symptoms, so they may be discovered later or incidentally on imaging.

Treatment can differ from PDAC and may include surgery, targeted therapies, hormone-related medications,
and other systemic treatments depending on grade, spread, and symptoms.

3) Other Rare Malignancies Involving the Pancreas

Occasionally, the pancreas is involved by other cancers, such as lymphoma or metastases from another primary tumor.
These situations change the diagnostic plan and treatment strategyone more reason why a tissue diagnosis and careful staging matter.

How Pancreatic Cancer Is Diagnosed

Diagnosis is usually a step-by-step process: symptoms (or an incidental imaging finding) lead to targeted imaging,
sometimes followed by endoscopic evaluation and biopsy. Then comes stagingfiguring out how far the cancer has spread
and “resectability,” meaning whether surgery is likely to remove it completely.

Common Symptoms and Red Flags

Symptoms depend on tumor location and size. Some common warning signs include:

• Jaundice (yellowing of skin/eyes), often with dark urine and light-colored stools
• Upper abdominal or back pain
• Unexplained weight loss and reduced appetite
• Fatigue
• Nausea, bloating, or changes in digestion
• New or suddenly worsening diabetes (in some people)

Example: A tumor in the head of the pancreas may block the bile duct, leading to painless jaundice.
That’s often a “go now” symptom because it can signal a blockage that needs urgent evaluation (whether cancer or not).

Blood Tests: Helpful, But Not a Standalone Diagnosis

Doctors may order liver function tests, blood sugar testing, and tumor markers such as CA 19-9.
CA 19-9 can be useful for monitoring treatment response in some cases, but it’s not reliable enough to diagnose pancreatic cancer by itself.
It can be elevated in non-cancer conditions too, and some people don’t produce CA 19-9 at all due to genetics.

Imaging Tests: Finding the “Where” and “How Big”

Imaging is the workhorse of pancreatic cancer evaluation. Depending on the situation, doctors may use:

• CT scan (often a specialized pancreas protocol) to evaluate the tumor and nearby vessels
• MRI and MRCP to assess ducts and soft tissue detail
• Ultrasound (including abdominal ultrasound), sometimes as a first look
• PET scans in selected cases to look for metastatic disease or clarify findings

Imaging helps answer key questions: Is there a mass? Is it involving major blood vessels? Are lymph nodes suspicious?
Are there signs of spread to the liver or other organs?

Endoscopic Tests: Getting Close (and Sometimes Getting Tissue)

When doctors need a closer lookor need a biopsythey often use endoscopic procedures:

• Endoscopic ultrasound (EUS): An endoscope with ultrasound lets specialists view the pancreas up close.
  EUS can also guide a needle biopsy (FNA/FNB) to obtain tissue.
• ERCP (endoscopic retrograde cholangiopancreatography): Often used when bile duct blockage is present.
  It can help place a stent to relieve jaundice and may obtain samples in certain situations.
• Diagnostic laparoscopy: In some cases, surgeons look for small metastases not obvious on imaging before committing to major surgery.

Reality check: There isn’t one magical test that’s perfect for everyone. The diagnostic plan is tailored
to symptoms, imaging findings, and whether surgery is being considered.

Staging and Resectability: The “Can We Remove It?” Question

After diagnosis, staging describes how advanced the cancer is. Clinicians often use the TNM system and then
translate it into practical categories that guide treatment:

• Resectable: Imaging suggests the tumor can be removed surgically with clear margins.
• Borderline resectable: Tumor involves nearby vessels in a way that might still allow surgery, often after pre-surgery therapy.
• Locally advanced: Tumor is too involved with major vessels to remove safely at diagnosis.
• Metastatic: Cancer has spread to distant organs (commonly the liver or peritoneum).

Example: Someone might have a tumor that’s touching a major vein. The team may recommend chemotherapy first
to shrink or stabilize it, then re-scan to see if surgery becomes safer and more effective. That’s not “delaying care”
it’s strategizing.

Molecular and Genetic Testing: Treatment Clues in Your DNA (and the Tumor’s)

Many cancer centers now consider genetic testing an important part of pancreatic cancer care:

• Germline testing (blood or saliva): looks for inherited mutations such as BRCA1/BRCA2 and others.
  These results can affect treatment and inform family members’ risk.
• Tumor testing (molecular profiling): looks for actionable tumor features, such as MSI-H/dMMR status
  or rare gene fusions/mutations that might open the door to targeted therapies.

The punchline: sometimes the tumor’s biology matters as much as its location. And unlike most plot twists, this one can be helpful.

How Pancreatic Cancer Is Treated

Treatment depends on tumor type (PDAC vs pNET), stage, overall health, and goals of care.
Most people benefit from a multidisciplinary teamoncology, surgery, radiation oncology, gastroenterology,
radiology, pathology, nutrition, and palliative care specialists working together.

Surgery: When Cure Is Possible, Surgery Is Usually Central

Surgery offers the best chance for long-term survival in resectable disease. The operation depends on tumor location:

• Whipple procedure (pancreaticoduodenectomy): often for tumors in the head of the pancreas
• Distal pancreatectomy: for tumors in the body or tail
• Total pancreatectomy: less common, removes the whole pancreas in select situations

Surgery is complex, so outcomes can be better at experienced, high-volume centers. Recovery involves managing pain,
nutrition, digestion changes (enzyme supplements may be needed), and sometimes diabetes.

Systemic Therapy (Chemo and Beyond): Treating the Whole Body

Systemic therapy travels through the bloodstream and can treat cancer cells beyond the primary tumor.
It’s used in several settings:

• Neoadjuvant (before surgery): often used for borderline resectable disease and sometimes resectable disease
• Adjuvant (after surgery): reduces the risk of recurrence
• Primary therapy for locally advanced or metastatic disease

Common first-line chemotherapy approaches for PDAC may include multi-drug regimens such as
FOLFIRINOX or gemcitabine + nab-paclitaxel, selected based on patient fitness
and side effect considerations.

What does “fitness” mean here? Not whether you can do 20 push-ups. More like whether your body can
safely tolerate an intensive regimen while still living your life, eating, sleeping, and healing.

Radiation Therapy and Chemoradiation: Targeting the Neighborhood

Radiation may be used in combination with chemotherapy (chemoradiation) or alone in certain circumstances,
particularly for locally advanced disease or to help manage symptoms such as pain.
The role of radiation can vary by center and situation, and treatment plans are often individualized.

Targeted Therapy and Precision Medicine: Small Subsets, Big Impact

Targeted therapy isn’t available for everyone with pancreatic cancer, but when it is, it can be meaningful.
One established example involves inherited BRCA mutations:

• For some people with metastatic pancreatic cancer and a germline BRCA mutation, a PARP inhibitor
  such as olaparib may be used as maintenance therapy after response to platinum-based chemotherapy.

Additional targeted options may be considered for rare molecular findings (for example, certain gene fusions or mutations),
typically guided by tumor profiling and specialist input.

Immunotherapy: Not for MostBut Powerful for a Few

Immunotherapy has historically been challenging in pancreatic cancer, but there are important exceptions.
Immune checkpoint inhibitors may be options when the tumor has specific biomarkers such as
MSI-H (microsatellite instability-high) or dMMR (deficient mismatch repair).
These markers are uncommon in pancreatic cancer, but when present, they can change the treatment conversation.

Palliative and Supportive Care: Comfort Is Not “Giving Up”

Palliative care focuses on symptom relief and quality of lifealongside cancer treatment, not only at end-of-life.
This can include:

• Stents to relieve bile duct blockage and jaundice
• Pain management strategies (medications, nerve blocks in select cases)
• Nutrition support and pancreatic enzyme replacement for digestion problems
• Diabetes management if pancreatic function is affected
• Support for fatigue, nausea, appetite, and emotional health

If anyone tries to tell you palliative care is “only hospice,” they are confidently incorrect.
(And confidence is not the same thing as correctnessespecially on the internet.)

Questions Worth Asking Your Care Team

Bringing questions to appointments can make the process feel less like a medical escape room. Consider asking:

• What type of pancreatic cancer do I have (PDAC vs pNET vs another subtype)?
• What stage is it, and is it resectable/borderline/locally advanced/metastatic?
• Do I need a biopsy, and what method is recommended (EUS-guided biopsy, etc.)?
• Should I get germline genetic testing? Should my tumor be profiled?
• What’s the goal of treatment right nowcure, control, shrink for surgery, symptom relief?
• What side effects are most likely, and how will we manage them?
• Are clinical trials appropriate for my situation?

Conclusion

Pancreatic cancer is complex, but understanding the basics helps you navigate it with fewer surprises.
The most important first step is clarifying what type of pancreatic cancer it is and
how far it has spread. From there, diagnosis and staging guide the plan: surgery when possible,
chemotherapy and/or radiation when needed, targeted or immune therapies for select biomarker-defined cases, and
supportive care throughout.

If you take one thing from this article, let it be this: the details matterand those details are knowable.
Ask questions. Get clarity. And lean on specialized teams who treat pancreatic cancer often. You deserve a plan
that fits your diagnosis, not a one-size-fits-nobody approach.

Experiences & Real-World Perspectives (What It Can Feel Like)

Medical explanations are useful, but people don’t live inside a staging chart. They live in weekdays, errands,
meals they can (or can’t) finish, and the mental gymnastics of waiting for scan results. While everyone’s
experience is different, there are patterns patients and caregivers often describe when dealing with
types of pancreatic cancer, how they’re diagnosed, and what treatment is like.

The “I Knew Something Was Off” Phase

Many people report that symptoms started out annoyingly ordinary. A vague backache. A weird loss of appetite.
Pants fitting differently (not the fun way). Some describe itching and jaundice that seemed to come out of nowhere,
especially when a tumor blocks the bile duct. Others talk about digestion changinggreasy stools, bloating,
or feeling full quicklybefore anyone says the word “pancreas.”

People with pancreatic neuroendocrine tumors sometimes describe a different path: episodes of sweating,
shakiness, or confusion that turn out to be low blood sugar from an insulin-secreting tumor, or stomach ulcers
that keep coming back due to excess hormone production. In those cases, the symptoms can be more specific,
even if the diagnosis still takes time.

Diagnosis Can Feel Like a Relay Race

A common experience is moving from one test to another: labs, imaging, then an endoscopic ultrasound with biopsy.
The waiting can be its own side effect. People often say the hardest part wasn’t the procedureit was the days
between “we see something” and “here’s exactly what it is.”

Many patients find it helpful to keep a small notebook (or phone note) with dates, test names, and questions.
It sounds simple, but when you’re juggling CT results, biopsy pathology, and appointments with multiple specialists,
your brain deserves a break from being the entire filing system.

Treatment Decisions: The Moment It Gets Real

If surgery is possible, the word “Whipple” can land like a piano. It’s a major operation, and people often describe
feeling a mix of relief (“there’s a plan”) and fear (“that’s a lot of anatomy to rearrange”). Those who go through it
frequently mention that recovery is not linear. One week you feel like a champion; the next week toast is suddenly
an ambitious goal. Small wins matter.

Chemotherapy experiences vary widely, but people often describe learning a new rhythm: infusion days, rest days,
“good” days, and days where even the smell of coffee is a personal attack. Regimens like FOLFIRINOX can be effective
but intense, and many patients talk about adjusting expectationsbeing proud of a short walk, celebrating a meal that
stays down, asking for help sooner instead of later.

Side Effects Aren’t Just Physical

Patients and caregivers commonly mention the emotional whiplash: hope after a good scan, dread before the next one,
and exhaustion from explaining updates to friends and family. Some people find comfort in setting “communication rules”
(for example: one family member shares updates to everyone else, so the patient doesn’t have to repeat the story
ten times a day like a news anchor who never asked for the job).

Nutrition changes are also a frequent real-world topic. People may need pancreatic enzyme replacements to digest fats
properly, or they may adjust meal patternssmaller meals, more frequent snacks, more protein, fewer “why is this suddenly
spicy?” surprises. It can take trial and error, and many people say a dietitian familiar with pancreatic cancer made a
bigger difference than they expected.

What Many People Wish They’d Known Earlier

• Second opinions are normal, especially at high-volume pancreatic cancer centers.
• Palliative care can help early with pain, nausea, appetite, and sleepwhile you’re still receiving treatment.
• Ask about genetic and tumor testing; sometimes it opens doors to targeted therapy or clinical trials.
• Support groups can be practical, not just emotionalpeople share tips that don’t show up in brochures.
• Bring someone to appointments when possible. Two sets of ears beat one, especially on big-decision days.

Ultimately, pancreatic cancer care is not just “treat the tumor.” It’s treat the whole personenergy, digestion,
mood, sleep, relationships, and the very human need to feel understood. If you’re navigating this as a patient or caregiver,
you’re not “being dramatic” for wanting clarity, comfort, and a plan that makes sense. You’re being appropriately informed.